NR2F6 and glioma: Analysis of mRNA expression profiles and protein expression levels revealed significant up-regulation in 25 cancer tissues and significant down-regulation in low-grade glioma (LGG), papillary cell carcinoma of the kidney (KIPAN), and clear cell carcinoma of the kidney (KIRC) tissues, suggesting distinct roles for NR2F6 in the development of different cancers.